OBJECTIVE: The aim of this review is to describe the most common recurring and chronic upper respiratory tract infections (URTI) in children and discuss the role of bacterial interference and bacteriotherapy in their prevention and treatment.MATERIALS AND METHODS: A literature review has been performed on the following topics: acute otitis media, adenoiditis. tonsillitis, rhinosinusitis, microbiotics and the role of bacterial interference, and bacteriotherapy in the prevention and treatment of URTI.RESULTS: Research studies into the characteristics of the microbiological flora and its role in the pathogenesis of URTI have focused on a single pathogen. on resistance to and ineffectiveness of antibiotic therapies, or on the persistence of bacterial biofilm. Recent evidence supports a central role of the existing microbial ecosystem in the pathogenesis of respiratory disease. In light of this, new therapeutic approaches include the implantation and persistence within the normal microflora of relatively innocuous "effector" bacteria that can competitively exclude or prevent the outgrowth of potentially disease-causing bacteria. Recently, a retrospective and observational study demonstrated that S. salivarius 24SMB and S. oralis 89a nasal spray could be effective in the prevention of recurrent otitis media in a real-life setting. Other studies have focused on the role of bacteriotherapy in children with beneficial effects in the prevention of URTI.CONCLUSIONS: The results of previous studies on the role of bacteriotherapy in paediatric URTI suggest that the use of bacterial interference phenomena through bacteriotherapy is a feasible, safe approach and deserves proper consideration as a promising therapeutic strategy against URTI.

Bellussi, L., Passali, F., Ralli, M., De Vincentiis, M., Greco, A., Passali, D. (2019). An overview on upper respiratory tract infections and bacteriotherapy as innovative therapeutic strategy. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 23, 27-38.

An overview on upper respiratory tract infections and bacteriotherapy as innovative therapeutic strategy

Passali, FM;
2019-03-01

Abstract

OBJECTIVE: The aim of this review is to describe the most common recurring and chronic upper respiratory tract infections (URTI) in children and discuss the role of bacterial interference and bacteriotherapy in their prevention and treatment.MATERIALS AND METHODS: A literature review has been performed on the following topics: acute otitis media, adenoiditis. tonsillitis, rhinosinusitis, microbiotics and the role of bacterial interference, and bacteriotherapy in the prevention and treatment of URTI.RESULTS: Research studies into the characteristics of the microbiological flora and its role in the pathogenesis of URTI have focused on a single pathogen. on resistance to and ineffectiveness of antibiotic therapies, or on the persistence of bacterial biofilm. Recent evidence supports a central role of the existing microbial ecosystem in the pathogenesis of respiratory disease. In light of this, new therapeutic approaches include the implantation and persistence within the normal microflora of relatively innocuous "effector" bacteria that can competitively exclude or prevent the outgrowth of potentially disease-causing bacteria. Recently, a retrospective and observational study demonstrated that S. salivarius 24SMB and S. oralis 89a nasal spray could be effective in the prevention of recurrent otitis media in a real-life setting. Other studies have focused on the role of bacteriotherapy in children with beneficial effects in the prevention of URTI.CONCLUSIONS: The results of previous studies on the role of bacteriotherapy in paediatric URTI suggest that the use of bacterial interference phenomena through bacteriotherapy is a feasible, safe approach and deserves proper consideration as a promising therapeutic strategy against URTI.
mar-2019
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/31 - OTORINOLARINGOIATRIA
English
Con Impact Factor ISI
OSAS; Children; Snoring; Multidisciplinary approach
Bellussi, L., Passali, F., Ralli, M., De Vincentiis, M., Greco, A., Passali, D. (2019). An overview on upper respiratory tract infections and bacteriotherapy as innovative therapeutic strategy. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 23, 27-38.
Bellussi, L; Passali, F; Ralli, M; De Vincentiis, M; Greco, A; Passali, D
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
bacteriotherapy.pdf

accesso aperto

Licenza: Non specificato
Dimensione 497.91 kB
Formato Adobe PDF
497.91 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/218470
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 14
social impact